- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05389930
Cannabisens inverkan på alkoholkonsumtionen
Cannabis inverkan på alkoholkonsumtion: integration av laboratorie- och ekologiska momentana bedömningsmetoder
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo.
The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
This study employs a repeated measures experimental design to examine the effect of THC-dominant (9.53% THC and 0.09% CBD) dose of cannabis and CBD-dominant (0.35% THC and 11.27% CBD) dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly to obtain the final sample of 200 with complete data. Participants will be tested at a baseline session, during three experimental sessions, and then during a subsequent 4-week period in the natural environment using a smart-phone application. Findings have important implications for cannabis regulatory science and alcohol use disorder treatment by addressing the relative impact of specific cannabinoids as well as contextual risk in cannabis-alcohol co-use.
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 2
Kontakter och platser
Studiekontakt
- Namn: Jane Metrik, PhD
- Telefonnummer: 401-863-6650
- E-post: Jane_Metrik@brown.edu
Studieorter
-
-
Rhode Island
-
Providence, Rhode Island, Förenta staterna, 02912
- Rekrytering
- Brown University
-
Kontakt:
- Jane Metrik, PhD
- Telefonnummer: 401-863-6650
- E-post: Jane_Metrik@brown.edu
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Age 21 to 50
- English-speaking
- cannabis smoking in past two months
- heavy drinking in past two months
- in good physical health and weighing < 250 lbs
- zero breath alcohol at each visit
Exclusion Criteria:
- positive pregnancy test
- nursing
- positive urine toxicology screen for drugs other than cannabis
- interest to quit or receive treatment for cannabis or alcohol use
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: THC-dominant cannabis dose
367 mg of cannabis plant material with 9.53% THC and 0.09% CBD and 217 mg of placebo cannabis plant material will be mixed and smoked in a handheld pipe |
Drink containing 0.3 g/kg of alcohol Placebo beverage contains only juice and a negligible trace of alcohol for masking |
|
Experimentell: CBD-dominant cannabis dose
367 mg of cannabis plant material with 11.27% CBD and 0.35% THC and 217 mg of placebo cannabis plant material will be mixed and smoked in a handheld pipe |
Drink containing 0.3 g/kg of alcohol Placebo beverage contains only juice and a negligible trace of alcohol for masking |
|
Placebo-jämförare: Placebo
584 mg of cannabis plant material will be smoked in a handheld pipe |
Drink containing 0.3 g/kg of alcohol Placebo beverage contains only juice and a negligible trace of alcohol for masking |
|
Experimentell: Alcohol priming dose
Alcohol: 0.3 g/kg. Alcohol priming drink is designed to raise blood alcohol levels to 0.03 g/dl and be consumed in 5 minutes. The drink is mixed using 80-proof liquor and juice. Participants are randomized to receive either the experimental alcohol priming dose or alcohol placebo. |
Smoked cannabis with 9.53% THC and 0.09% CBD Smoked cannabis with 0.35% THC and 11.27% CBD Smoked placebo cannabis plant material |
|
Placebo-jämförare: Alcohol placebo dose
Placebo beverage contains only juice and a negligible trace of alcohol for masking. The weight and sex-adjusted volume of alcohol and non-alcohol containing beverages will be equal. Participants are randomized to receive either the experimental alcohol priming dose or alcohol placebo. |
Smoked cannabis with 9.53% THC and 0.09% CBD Smoked cannabis with 0.35% THC and 11.27% CBD Smoked placebo cannabis plant material |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
ml of alcohol consumed
Tidsram: post-smoking during two-hours of the alcohol choice task
|
ml of alcohol consumed during the alcohol choice task |
post-smoking during two-hours of the alcohol choice task
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Jane Metrik, PhD, Brown University
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2022003195
- R01AA029711 (U.S.S. NIH-anslag/kontrakt)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .